English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/213997
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Selectivity and Physicochemical Optimization of Repurposed Pyrazolo[1,5-b]pyridazines for the Treatment of Human African Trypanosomiasis

AuthorsTear, WF; Bag S; Diaz-Gonzalez, R; Ceballos-Pérez, G; Rojas-Barros, Domingo I.; Cordon-Obras, Carlos; Pérez-Moreno, G; García-Hernández, R; Martinez-Martinez, MS; Ruiz-Pérez, Luis Miguel; Gamarro, Francisco; González- Pacanowska, D.; Caffrey, CR; Ferrins, L; Manzano, P; Navarro, M.; Pollastri, MP
Issue Date2020
PublisherAmerican Chemical Society
CitationJournal of Medicinal Chemistry 63: 756- 783 (2020)
AbstractFrom a high-throughput screen of 42 444 knownhuman kinases inhibitors, a pyrazolo[1,5-b]pyridazine scaffold wasidentified to begin optimization for the treatment of human Africantrypanosomiasis. Previously reported data for analogous com-pounds against human kinases GSK-3β, CDK-2, and CDK-4 wereleveraged to try to improve the selectivity of the series, resulting in23awhich showed selectivity forT. b. bruceiover these threehuman enzymes. In parallel, properties known to influence theabsorption, distribution, metabolism, and excretion (ADME)profile of the series were optimized resulting in20gbeingprogressed into an efficacy study in mice. Though20gshowedtoxicity in mice, it also demonstrated CNS penetration in a PKstudy and significant reduction of parasitemia in four out of the sixmice.
Identifiersdoi: 10.1021/acs.jmedchem.9b01741
issn: 0022-2623
e-issn: 1520-4804
Appears in Collections:(IPBLN) Artículos
Files in This Item:
File Description SizeFormat 
779338.pdf3,67 MBUnknownView/Open
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.